In experimental models of chronic renal failure blockade of the renin-angiotensin system (RAS), the endothelin (ET) system, pharmacological and mechanical inhibition of the sympathetic nervous system, and blockade of the FGF23-axis [9–13] were also shown to be successful. The gene discussed is FGF23; the disease is chronic kidney disease.